Stepan Company
SCLBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframeHeadquartered within the basic materials sector, Stepan Company focuses on Specialty Chemicals services and products. Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in the United States, France, Poland,. At a $1.41B market cap, Stepan Company ranks as a small-cap company within basic materials. It operates through three segments: Surfactants, Polymers, and Specialty Products.
Market Cap
$1.41B
Beta
0.94
P/E (TTM)
—
P/E (Fwd)
16.86
EPS (TTM)
$-0.12
EPS (Fwd)
$3.69
ROE
-0.2%
ROA
2.1%
Cash
$113.7M
Total Debt
$707.3M
Free CF
$55.5M
52W Change
32.0%
Annual Financials
Cash vs Debt
Where SCL stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, SCL finished 13.58% above its 150-day moving average ($54.73) and 17.70% above its 200-day moving average ($52.81). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SCL overbought or oversold?
At the September 3, 2026 close, SCL's RSI(14) was 29.3, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, SCL has $113.7M in cash with $707.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $55.5M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at -0.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $2.77B (2022) to $2.33B (2025), a 16% decline worth watching.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Stepan Company's trajectory.